IN VITRO DISSOLUTION AND PILOT PHARMACOKINETIC STUDIES OF ACETYLSALICYLIC ACID FROM AN ORALLY DISINTEGRATING TABLET FORMULATION OF LOW-DOSE ASPIRIN

Journal Title: International Journal of Medical and Clinical Research - Year 2011, Vol 2, Issue 2

Abstract

Purpose: Low-dose aspirin (acetylsalicylic acid; ASA) is in routine use today in preventing myocardial infarction and cardiovascular events. Fasprin® (ASA, 81 mg) is a new orally disintegrating tablet formulation of low-dose ASA (ODA) that was designed as a fast-acting, quick-dissolving solid dosage form. The purpose of this work was to (1) evaluate, comparatively, the in vitro dissolution, and (2) evaluate the absorption kinetics of ASA in healthy adults following oral administration of the ODA product. Methods: USP type II dissolution apparatus was implemented in the dissolution studies. For the pharmacokinetic studies, a single ODA dose was administered and blood samples were collected and analyzed for ASA content using a validated HPLC method. Absorption-related pharmacokinetic parameters were estimated using WinNonlin®. Results: Dissolution rate and extent of ASA from the ODA formulation were either higher than or similar to those from leading aspirin-containing products. Noncompartmental pharmacokinetic analysis of ASA plasma profiles from the ODA product revealed a lag-time of at least three minutes. The maximum concentration (Cmax) of ASA was 0.61 µg/mL and the time of Cmax (tmax) ranged from 15 - 75 minutes. The elimination rate constant of ASA was 0.0245 min-1, corresponding to a terminal t½ of 28.3 minutes. Conclusion: The ODA product demonstrated favorable dissolution compared to some leading ASA-containing products. It also provided systemic concentration of ASA at a relatively early time. While the overall absorption kinetics of the ODA product was generally comparable to those from other low-dose ASA-containing products, a direct product comparison is warranted.

Authors and Affiliations

ROJEAB YOUSIF, MARTIN B. SHANE, ROBIN WHITE, SUSAN MONTENERY, MARY MCWILLIAMS, MARJORIE WALKER, DAVID KISOR

Keywords

Related Articles

PREGNANCY OUTCOME IN POST SPLENECTOMY PATIENT WITH HEREDITARY SPHEROCYTOSIS – A CASE REPORT

Hereditary spherocytosis (HS) is a rare type of hemolytic anemia in southeast-Asian population whereas it is common among western countries like north Europe. Hereditary Spherocytosis (HS) is most common red cell membran...

STUDY OF BIOLOGICAL EFFECTS WHEN EXPOSURE TO He-Ne LASER AND UVC RADIATION ON HEAD SPERM ABNORMALITIES IN MICE

In vitro, He-Ne laser show a modifying response of cells to ionizing radiations. So there is a need to show the effect of He-Ne laser (632.8 nm), Ultraviolet radiation UVC (250 nm) and He-Ne laser pre and post irradiatio...

A STUDY OF PHARMACOKINETICS OF ATORVASTATIN ON TYPE 2 DIABETIC & DYSLIPIDEMIC BENGALI POPULATION OF INDIA AND BANGLADESH

Objective: Type 2 diabetes (T2DM) is a global problem and WHO reported one million one hundred thousand deaths per year globally due to diabetes [1]. T2DM increases the mortality due to cardiovascular disease [2]. The st...

PROTEINS OF CLASSICAL AND LECTIN PATHWAY OF THE COMPLEMENT SYSTEM INVOLVED IN THE PATHOGENESIS OF RHEUMATIC HEART DISEASE

Background: Rheumatic heart disease is an inflammatory disease which predominantly affects the valvular endocardium culminating in crippling valve deformities. Inorder to find out the role of complement proteins in induc...

LAPAROSCOPY IN 50 INFERTILE COUPLES: PROSPECTIVE STUDY

Use of diagnostic and therapeutic laparoscopy in infertility has been a focus of attention in recent years and demonstrated to be very effective method in evaluating these cases.. In our study, we were able to carry out...

Download PDF file
  • EP ID EP170030
  • DOI 10.9735/0976-5530.2.2.72-77
  • Views 68
  • Downloads 0

How To Cite

ROJEAB YOUSIF, MARTIN B. SHANE, ROBIN WHITE, SUSAN MONTENERY, MARY MCWILLIAMS, MARJORIE WALKER, DAVID KISOR (2011). IN VITRO DISSOLUTION AND PILOT PHARMACOKINETIC STUDIES OF ACETYLSALICYLIC ACID FROM AN ORALLY DISINTEGRATING TABLET FORMULATION OF LOW-DOSE ASPIRIN. International Journal of Medical and Clinical Research, 2(2), 72-77. https://europub.co.uk/articles/-A-170030